PATENT CLAIM ANALYSIS

Application Number: 15976516
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "489000"]

Abstract:
Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also contemplated.

Claim (Index 83):
The pharmaceutical composition of  claim 81 , wherein said concentration of said at least one antiarrhythmic pharmaceutical agent is about 35 mg/mL.

Metadata:
- Claim Count in Document: 100.0
- Percentile: 93.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14632252', '15928851', '13257249', '15422053', '11667139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7619875399890899
- 35 USC 102 Novelty (BERT): 0.5325751377109896
- Combined Prediction Score: 0.7390462997612799
- Mean Citation Score: 298.5265720000001
- Max Citation Score: 356.22864
- Similarity Product: 199.1613076680851

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test